Canada Markets closed
  • S&P/TSX

    21,637.54
    -15.48 (-0.07%)
     
  • S&P 500

    4,704.54
    +15.87 (+0.34%)
     
  • DOW

    35,870.95
    -60.10 (-0.17%)
     
  • CAD/USD

    0.7936
    -0.0001 (-0.0095%)
     
  • BTC-CAD

    74,315.70
    +1,853.37 (+2.56%)
     
  • CMC Crypto 200

    1,402.14
    -65.80 (-4.48%)
     
  • GOLD FUTURES

    1,861.20
    -0.20 (-0.01%)
     
  • RUSSELL 2000

    2,363.59
    -13.42 (-0.56%)
     
  • 10-Yr Bond

    1.5890
    -0.0150 (-0.94%)
     
  • NASDAQ futures

    16,494.75
    +13.50 (+0.08%)
     
  • VOLATILITY

    17.59
    +0.48 (+2.81%)
     
  • FTSE

    7,255.96
    -35.24 (-0.48%)
     
  • NIKKEI 225

    29,683.09
    +84.43 (+0.29%)
     
  • CAD/EUR

    0.6979
    +0.0004 (+0.06%)
     

Global Technetium Market (2021 to 2026) - Featuring American Elements, Bayer and Covidien Among Others - ResearchAndMarkets.com

·4 min read

DUBLIN, October 25, 2021--(BUSINESS WIRE)--The "Global Technetium Market Outlook to 2026" report has been added to ResearchAndMarkets.com's offering.

This report provides deep insights into the current and future state of the technetium market across various regions. The study comprehensively analyzes the technetium market by segmenting based on type (Metal Powder, Metal Crystal), production (Nuclear Fission Product, Neutron Activation, Particle Accelerator), application (Nuclear Medicine and Biology, Industrial and Chemical, and Others), and geography (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The report examines the market drivers and restraints, along with the impact of Covid-19 on the market's growth, in detail. The study covers & includes emerging market trends, developments, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with profiles of major companies, including their market shares and projects.

According to the publisher, the global technetium market is expected to witness growth at a considerable rate during the forecast period. The major factors responsible for the global technetium market's growth would be the increasing demand for nuclear medicines and extended employment of myocardial perfusion imaging in detecting rapidly spreading coronary heart diseases. The invention of PET and SPECT scans have revolutionized global medical diagnostic studies. Technetium-99 based imaging techniques are predominantly used to completely understand the human body and detect bone metastases and extended bone diseases, including inflammation. Various other chemical forms of this metal take part in imaging different body parts such as lungs, kidneys, brain, and thyroid. Despite having important radiopharmaceutical and radiotherapeutic applications, technetium's radioactivity causes production, storage, and transportation issues. Technetium-99's supply is unstable, and the market is highly dependent on a small number of organizations handling this metal. Thus, stringent government policies, along with technetium's logistical and toxicological problems, restrain the global technetium market.

Boasting high development, North America has been the largest market for global technetium due to the demand for advanced medical facilities here. The growth here is, however, expected to be much slower when compared to the Asia-Pacific region. Substantial investments towards the healthcare sector, skyrocketing improvements in living standards, and population-driven urge for better medical facilities make Asia-Pacific a high potential market during the forecast period.

NorthStar Medical Technologies, a global innovator in the production and distribution of radioisotopes used for medical imaging, announced on March 3, 2020, that it has entered into a worldwide, exclusive licensing agreement with Capella Imaging, a BioGenerator company, to develop a fibrin-targeted diagnostic imaging agent, FibroScint (Tc-99m F4A), for cardiac imaging. If successfully developed and approved, it may have potential applications across multiple cardiovascular conditions such as thrombus (blood clots) associated with left ventricular assist devices (LVADs), deep vein thrombosis, pulmonary embolism, and acute coronary syndrome.

Thousands of cancer screenings and other crucial procedures were expected to have been canceled on 21st October 2020, after a fresh incident at Lucas Heights, Australia's only nuclear medical facility. A fault at the nuclear medical facility over the weekend caused the short-term shortage of molybdenum-99, a commonly used isotope in nuclear medicine, whose supply is vital as a raw material for technetium-99m production, which in turn is used in imaging techniques and radiotherapies.

Key Topics Covered:

1. Executive Summary

2. Research Scope and Methodology

3. Market Analysis

3.1 Introduction

3.2 Market Dynamics

3.2.1 Drivers

3.2.2 Restraints

3.3 Market Trends & Developments

3.4 Market Opportunities

3.5 Feedstock Analysis

3.6 Regulatory Policies

3.7 Analysis of Covid-19 Impact

4. Industry Analysis

4.1 Supply Chain Analysis

4.2 Porter's Five Forces Analysis

4.2.1 Competition in the Industry

4.2.2 Potential of New Entrants into the Industry

4.2.3 Bargaining Power of Suppliers

4.2.4 Bargaining Power of Consumers

4.2.5 Threat of substitute products

5. Market Segmentation & Forecast

5.1 By Type

5.1.1 Metal Powder

5.1.2 Metal Crystal

5.2 By Production

5.2.1 Nuclear Fission Product

5.2.2 Neutron Activation

5.2.3 Particle Accelerator

5.3 By Application

5.3.1 Nuclear Medicine and Biology

5.3.2 Industrial and Chemical

5.3.3 Others

6. Regional Market Analysis

7. Key Company Profiles

7.1 Advanced Accelerator Applications

7.2 Advanced Cyclotron Systems

7.3 American Elements

7.4 Bayer AG

7.5 Covidien

7.6 Curium Pharma

7.7 Eckert & Ziegler

7.8 GE Healthcare

7.9 Ion Beam Applications

7.10 Jubilant Life Sciences

7.11 Lantheus Medical Imaging

7.12 Mallinckrodt

7.13 NorthStar Medical Technologies

7.14 Siemens Healthineers

7.15 Sumitomo Heavy Industries

*List of companies is not exhaustive

8. Competitive Landscape

9. Conclusions and Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/7y5gk4

View source version on businesswire.com: https://www.businesswire.com/news/home/20211025005711/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting